Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. (Q53591737)
Jump to navigation
Jump to search
scientific article published in October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. |
scientific article published in October 2006 |
Statements
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors. (English)
Robert Vessella
Ilsa Coleman
Jennifer D Wu
Kathy Haugk
Lillie Woodke
Peter Nelson
R Bruce Montgomery
Dale L Ludwig
Stephen R Plymate
1 October 2006
12
20 Pt 1
6153-6160